NCT04718532

Brief Summary

With the advent of the era of precision medicine, based on FFA image deep learning to identify the area of fundus lesions, registration of fundus images, according to the severity of fundus diseases to design the optimal laser energy and path, the accurate treatment of fundus diseases has urgent clinical needs and very important significance

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

January 18, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 22, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

January 22, 2021

Status Verified

January 1, 2021

Enrollment Period

7 years

First QC Date

January 18, 2021

Last Update Submit

January 18, 2021

Conditions

Retina Disorder

Outcome Measures

Primary Outcomes (1)

  • artificial intelligence

    using data to develop deep learning models

    2016.01-2023.12

Study Arms (1)

patients

patients with retinal diseases

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients undergo retinal exmination at eye center in the Second Affiliated Hospital of Zhejiang University

You may qualify if:

  • patients with retinal diseases

You may not qualify if:

  • patients with other disease affect retinal exmination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Zhejiang University

Hanzhou, Zhejiang, China

RECRUITING

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Jin Kai, MD

    Zhejiang University

    PRINCIPAL INVESTIGATOR

  • Xu Yufeng, MD

    Zhejiang University

    PRINCIPAL INVESTIGATOR

  • Lou Lixia, MD

    Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jin Kai, MD

CONTACT

13646828461jinkai@zju.edu.cn

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Target Duration
4 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2021

First Posted

January 22, 2021

Study Start

January 1, 2016

Primary Completion

January 1, 2023

Study Completion

December 31, 2023

Last Updated

January 22, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)